These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 33081995)
1. Predictors of good visual outcomes in patients with neovascular age-related macular degeneration in daily practice. Prieto-Del-Cura M; Villafruela-Güemes I; Recio-Gamo E; Sastre-Ibañez M; Fuentes-Ferrer ME J Fr Ophtalmol; 2020 Dec; 43(10):989-995. PubMed ID: 33081995 [TBL] [Abstract][Full Text] [Related]
2. Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial). Menon G; Chandran M; Sivaprasad S; Chavan R; Narendran N; Yang Y Eye (Lond); 2013 Aug; 27(8):959-63. PubMed ID: 23743535 [TBL] [Abstract][Full Text] [Related]
3. SEVERE VISUAL LOSS DURING ANTI-VEGF INTRAVITREAL INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: TIMING, PROGNOSIS, AND OPTICAL COHERENCE TOMOGRAPHY FINDINGS. Grassi MO; Monteleone G; Pozharitskiy N; Molfetta T; Boscia G; Alessio G; Boscia F Retina; 2023 Jul; 43(7):1081-1087. PubMed ID: 36913628 [TBL] [Abstract][Full Text] [Related]
4. Association between Retinal Thickness Variability and Visual Acuity Outcome during Maintenance Therapy Using Intravitreal Anti-Vascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration. Lai TYY; Lai RYK J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683165 [TBL] [Abstract][Full Text] [Related]
5. Predictors of stoppage and recurrence of choroidal neovascularization with a Treat- Extend-Stop protocol: 4-year follow-up. Garay-Aramburu G; Rodriguez-Feijoo D; Aldazabal-Echeveste M; Del Barrio Z; Eiras-Fernández A; Piñero DP; Larrauri-Arana A J Fr Ophtalmol; 2023 Dec; 46(10):1204-1211. PubMed ID: 37658033 [TBL] [Abstract][Full Text] [Related]
6. Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema. Quah NQX; Javed KMAA; Arbi L; Hanumunthadu D Clin Ophthalmol; 2024; 18():1479-1490. PubMed ID: 38827773 [TBL] [Abstract][Full Text] [Related]
7. Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen. Hujanen P; Ruha H; Lehtonen E; Pirinen I; Huhtala H; Vaajanen A; Syvänen U; Tuulonen A; Uusitalo-Järvinen H BMJ Open Ophthalmol; 2023 Aug; 8(1):. PubMed ID: 37586826 [TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence-based predictions in neovascular age-related macular degeneration. Ferrara D; Newton EM; Lee AY Curr Opin Ophthalmol; 2021 Sep; 32(5):389-396. PubMed ID: 34265783 [TBL] [Abstract][Full Text] [Related]
9. The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results. Khanani AM; Aziz AA; Khan H; Gupta A; Mojumder O; Saulebayeva A; Abbey AM; Almeida DRP; Avery RL; Banda HK; Barakat MR; Bhandari R; Chang EY; Haug SJ; London NJS; Mein L; Sheth VS; Wolfe JD; Singer MA; Danzig CJ Eye (Lond); 2023 Dec; 37(17):3574-3581. PubMed ID: 37173428 [TBL] [Abstract][Full Text] [Related]
16. Reliability of self-measurement of visual acuity in AMD patients with two electronic devices based on the ETDRS chart: A randomized study. Queguiner F; Bezirganyan K; Courjaret JC; Curel L; Penaranda G; Bonomini J; Righini Chossegros M J Fr Ophtalmol; 2024 Jan; 47(1):103911. PubMed ID: 37648551 [TBL] [Abstract][Full Text] [Related]
17. Intraocular inflammation as a major adverse event of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: from clinical trials to real-world practice. Kim JH Expert Opin Drug Saf; 2024 Jun; 23(6):659-661. PubMed ID: 38696228 [No Abstract] [Full Text] [Related]
18. [Quality of life survey of 3,738 patients treated with intravitreal injections for age-related macular degeneration]. Uzzan J; Haddad M; Salamé N J Fr Ophtalmol; 2024 Mar; 47(3):104075. PubMed ID: 38368762 [TBL] [Abstract][Full Text] [Related]
19. Is Exudative Neovascular AMD a Chronic Disease? Analysis of Long-term Progression under Anti-VEGF Therapy. Gunnemann ML; Ziegler M; Book M; Gunnemann F; Rothaus K; Spital G; Gutfleisch M; Lange C; Lommatzsch AP; Pauleikhoff D Klin Monbl Augenheilkd; 2024 Jul; ():. PubMed ID: 38181813 [TBL] [Abstract][Full Text] [Related]
20. Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response-a scoping review. Dervenis N; Dervenis P; Agorogiannis E BMJ Open Ophthalmol; 2024 Feb; 9(1):. PubMed ID: 38341189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]